RecruitingNCT07040592
Semaglutide for alcohol use and HIV care: a pilot study
About this title
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Read the official source — NCT07040592Medication studyAges 18–99United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 99 years.
- Listed locations
- DecaturSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 15, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT07040592
- Official title
Show the full official title
Feasibility, Acceptability, and Preliminary Efficacy of Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: An Open-Label Pilot Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Decatur
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including semaglutide.
Who can participate?
Listed age limits: 18 years to 99 years.
Is this study still recruiting?
The registry lists this study as recruiting.
